Shots:

• Medtronic has received CE Mark for its MiniMed 780G system- a closed-loop insulin pump designed to treat T1D patients aged 7-80 yrs. The system utilizes SmartGuard algorithm and stabilizes blood sugar levels and further improves glucose control
• The MiniMed 780G system enables the personalization of glucose goals with an adjustable target setting as low as 100 mg/dL (5.5 mmol/L). The system automates the delivery of both basal insulin and correction boluses every 5mins. to help diabetic patients avoid highs and lows in blood sugar
• Additionally- the Bluetooth connectivity of the system enables user’s real-time glucose data and trends on compatible iOS and Android smartphones via apps. The company expects to launch MiniMed 780G system in select European countries in H2’20

Click here to read full press release/ article | Ref: Medtronic | Image: Medtronic